Ray Co., Ltd. Stock: price and insider trades · South Korea

Ray Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). 10 insiders have disclosed 28 filings since 22 October 2025.

The record shows 14 purchases on the open market worth €2.5M, made by 6 insiders, against 3 sales worth €117k by 3 insiders. The totals exclude 13 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 2 board members, 2 senior executives and 1 major shareholder among the declarants. Biggest ticket of the year: €2.3M, bought by 메가젠임플란트 and made public on 8 April 2026 (4.5% of market cap).

In all, 2 purchases were made within 30 days of a purchase by another insider of the company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last insider purchase was made public on 13 July 2026, 119 days ago. Typically, a trade is published a median of 7 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.

Compared with its exchange (2,650 companies, median 7 filings), a count of 28 filings is above the norm. Over the whole record (from 2021), the tally stands at 40 purchases and 73 sales.

Elsewhere in the same sector, our signals recently picked up insider purchases at UCB. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.